Why the study?
Does platelet reactivity and genotype testing improve outcomes in patients with ACS and PCI treated with clopidogrel?
Does platelet reactivity and genotype testing improve outcomes in patients with ACS and PCI treated with clopidogrel?
The clinical utility of platelet reactivity and genotype testing to guide clopidogrel therapy in ACS and PCI remains unproven.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Krishna et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: